Unilever Positioning Stays Loose Ahead of Tuesday's Results

UL reports results on Tuesday with short sellers showing no conviction against the stock, a picture that has shifted only modestly since the previous preview published four days ago.

The most notable change is a 15% jump in shares short on October 29, taking the count to around 4.6 million. That follows a week of net covering and leaves the overall level lower than it was through most of October, when short interest ran closer to 5 million to 5.6 million shares. Borrow costs have moved in the same direction, up 46% on the week to 0.45%, though that number remains firmly in low-cost territory and is well below the levels that prevailed in late September. Availability is expansive at 1,435%, meaning lenders hold roughly fourteen shares available for every one already borrowed. There is no meaningful friction in the borrow market.

Options traders are, if anything, slightly more relaxed than usual. The put/call ratio of 0.79 is fractionally below its 20-day average and carries a z-score of minus 0.56, pointing to a mild tilt toward calls rather than defensive puts. That positioning has barely moved for weeks, a stretch in which the ratio has not once touched either extreme of its 52-week range. Against a stock that is up 6.5% over the past month but off about 1.5% in the past week, the derivatives market is conveying no particular anxiety about the release. The ORTEX short score of 28.9 ranks in the 89th percentile for short-squeeze resilience, another way of saying short pressure is contained.

The debate around Unilever centres on whether the momentum from Q3 can hold. The company's third-quarter update, released on October 23, showed revenue growth of 4.2% against a consensus expectation of 3.1%, and management raised full-year organic growth guidance to 3.5%. BlackRock has added to its position, reporting a holding of around 8.6% as of late September. The valuation picture is not cheap by any measure: the PE ratio runs near 17.2 and price-to-book near 7.6, both meaningfully above the peer group in consumer staples. That premium holds as long as the margin story stays intact, which makes Tuesday's print less about the top line and more about what the company says on operating costs and the pace of its portfolio restructuring.

Tuesday's report will test whether Unilever can sustain the combination of pricing power and emerging-market volume recovery that drove the Q3 beat, at a valuation that already prices in a considerable amount of good news.